Table of Contents:

1 Report Prologue
2 Market Introduction
2.1 Definition
2.2 Scope of Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations
2.5 Market Structure
3 Research Methodology
3.1 Primary Research Methodology
3.2 Secondary Research Methodology
3.3 Market Share Analysis
3.4 Market Pricing Approach
4 Market Factor Analysis
4.1 Value Chain Analysis
4.1.1 R&D and Designing
4.1.2 Manufacturing
4.1.3 Distribution & sales
4.1.4 Post-sales monitoring
4.2 Porter's Five Forces Model
4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining power of buyers
4.2.3 Threat of new entrants
4.2.4 Threat of substitutes
4.2.5 Intensity of rivalry
4.3 Demand & Supply: Gap Analysis
4.4 Pricing Analysis
5 Market Dynamics
5.1 Introduction
5.2 Drivers
5.2.1 Increasing prevalence of cardiovascular diseases
5.2.2 Favourable reimbursement policies
5.2.3 Increasing geriatric population
5.3 Restraints
5.3.1 Strict regulatory guidelines
5.4 Mega Trends
5.5 Macroeconomic Indicators
6 Global Cardiovascular Application Market by Device
6.1 Introduction
6.2 Cardiac Monitors
6.3 Cardiac Pacemakers
6.4 Cardiac Defibrillators
7 Global Cardiovascular Application Market By End User
7.1 Introduction
7.2 Hospitals
7.3 Cardiac Care Centers
7.4 Ambulatory Centers & Home Care
7.5 Academic Centers
8 Global Cardiovascular Application Market by Region
8.1 Introduction
8.2 Americas
8.2.1 North America
8.2.1.1 U.S.
8.2.1.2 Canada
8.2.2 South America
8.3 Europe
8.3.1 Western Europe
8.3.1.1 Germany
8.3.1.2 France
8.3.1.3 UK
8.3.1.4 Italy
8.3.1.5 Spain
8.3.1.6 Rest of Western Europe
8.3.2 Eastern Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 Republic of Korea
8.4.6 Rest of Asia Pacific
8.5 Middle East & Africa
8.5.1 United Arab Emirates
8.5.2 Saudi Arabia
8.5.3 Oman
8.5.4 Kuwait
8.5.5 Qatar
8.5.6 Rest of Middle East & Africa
9 Company Landscape
9.1 Introduction
9.2 Company Share Analysis
9.3 Key Developments
10 Company Profiles
10.1 Abbott
10.1.1 Company Overview
10.1.2 Financials
10.1.3 Products
10.1.4 Strategy
10.1.5 Key Developments
10.2 General Electric Company
10.2.1 Company Overview
10.2.2 Financials
10.2.3 Products
10.2.4 Strategy
10.2.5 Key Developments
10.3 Medtronic
10.3.1 Company Overview
10.3.2 Financials
10.3.3 Products
10.3.4 Strategy
10.3.5 Key Developments
10.4 Boston Scientific Corporation
10.4.1 Company Overview
10.4.2 Financials
10.4.3 Products
10.4.4 Strategy
10.4.5 Key Developments
10.5 Koninklijke Philips N.V
10.5.1 Company Overview
10.5.2 Financials
10.5.3 Products
10.5.4 Strategy
10.5.5 Key Developments
10.6 Terumo
10.6.1 Company Overview
10.6.2 Financials
10.6.3 Products
10.6.4 Strategy
10.6.5 Key Developments
10.7 Stryker Corporation
10.7.1 Company Overview
10.7.2 Financials
10.7.3 Products
10.7.4 Strategy
10.7.5 Key Developments
11 Conclusion
11.1 Key Findings
11.1.1 CEO's Viewpoint
11.1.2 Unmet Needs
11.1.3 Key Companies to Watch
12 Appendix
12.1 Discussion Blue Print
12.2 References